Clinical Trials Logo

Hallucinations clinical trials

View clinical trials related to Hallucinations.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04248010 Withdrawn - Clinical trials for Schizophrenia and Related Disorders

Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in Schizophrenia

Start date: December 2022
Phase: N/A
Study type: Interventional

This project compares standard tDCS to individualized high-definition tDCS (HD-tDCS) for treatment of auditory verbal hallucinations in schizophrenia.

NCT ID: NCT02661347 Withdrawn - Schizophrenia Clinical Trials

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of transcranial direct current stimulation (tDCS) for the treatment of auditory hallucinations in patients currently on risperidone treatment who are experiencing recent onset psychosis.

NCT ID: NCT02240446 Withdrawn - Schizophrenia Clinical Trials

Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients

Start date: June 2013
Phase: N/A
Study type: Interventional

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel neuromodulation approaches using transcranial direct current stimulation (tDCS) for treating schizophrenia patients with medication-resistant auditory hallucinations. The investigators will use tDCS to stimulate prefrontal cortex. TDCS is a non-invasive brain stimulation technique that can modulate brain connectivity. Non-invasive brain neuromodulation will be combined (paired-neuromodulation) with training of a task that requires top-down control of auditory processes. Paired-neuromodulation can potentially be used as a therapeutic intervention to decrease auditory hallucinations in schizophrenia.